Latest work from our exciting collaborative research applying behavioral economics to MS-related behavior: “Probability discounting of treatment decisions in multiple sclerosis: associations with disease knowledge, neuropsychiatric status, and adherence” h
RT @OhioHealthMS: Probability discounting of treatment decisions in multiple sclerosis: associations with disease knowledge, neuropsychiatr…
RT @GavinGiovannoni: Clearly medical decision-making is more complex than I thought. #ClinicSpeak Probability discounting of treatment deci…
RT @OhioHealthMS: Probability discounting of treatment decisions in multiple sclerosis: associations with disease knowledge, neuropsychiatr…
Clearly medical decision-making is more complex than I thought. #ClinicSpeak Probability discounting of treatment decisions in MS: associations with disease knowledge, neuropsychiatric status, and adherence. https://t.co/tl0dbBaSNy https://t.co/vzwhJkOLXt
RT @OhioHealthMS: Probability discounting of treatment decisions in multiple sclerosis: associations with disease knowledge, neuropsychiatr…
RT @OhioHealthMS: Probability discounting of treatment decisions in multiple sclerosis: associations with disease knowledge, neuropsychiatr…
RT @OhioHealthMS: Probability discounting of treatment decisions in multiple sclerosis: associations with disease knowledge, neuropsychiatr…
RT @OhioHealthMS: Probability discounting of treatment decisions in multiple sclerosis: associations with disease knowledge, neuropsychiatr…
Probability discounting of treatment decisions in multiple sclerosis: associations with disease knowledge, neuropsychiatric status, and adherence. - PubMed - NCBI https://t.co/DedKYCLOKd
Probability discounting of treatment decisions in multiple sclerosis: associations with disease knowledge, neuropsychiatric status, and adherence. https://t.co/7duXrrNoqo
Probability discounting of treatment decisions in multiple sclerosis: associations with disease knowledge, neuropsychiatric status, and adherence. https://t.co/QeVW6Q0cdu
Probability discounting of treatment decisions in multiple sclerosis - https://t.co/EeEyXYBTGK #GoogleAlerts